{
 "url": "https://etfiq.com/funds/helx/holdings/",
 "section": "funds",
 "title": "HELX Holdings: All 61 Positions (Jun 30, 2026) | ETFIQ",
 "description": "All 61 HELX holdings with weights, as of Jun 30, 2026. The top 3 are Guardant Health Inc 9.09%, NTRA 7.46% and KRYS 6.33%. Free CSV download.",
 "as_of": "Jun 30, 2026",
 "ticker": "HELX",
 "fund": "Franklin Genomic Advancements ETF",
 "fund_page": "https://etfiq.com/funds/helx",
 "positions": 61,
 "positions_listed_on_page": 61,
 "lead": "HELX held 61 positions as of Jun 30, 2026. Guardant Health Inc is the largest at 9.09%; the top 10 are 47.0% of the fund.",
 "source": {
  "name": "Form N-PORT filed with the SEC",
  "url": "https://www.sec.gov/Archives/edgar/data/1655589/000094040026035124/primary_doc.xml",
  "document": "the fund’s SEC filing",
  "book_date": "2026-06-30",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Guardant Health Inc",
   "ticker": "GH",
   "weight_pct": 9.09,
   "page": "https://etfiq.com/holdings/gh/"
  },
  {
   "rank": 2,
   "holding": "Natera Inc",
   "ticker": "NTRA",
   "weight_pct": 7.461,
   "page": "https://etfiq.com/holdings/ntra/"
  },
  {
   "rank": 3,
   "holding": "Krystal Biotech Inc",
   "ticker": "KRYS",
   "weight_pct": 6.329,
   "page": "https://etfiq.com/holdings/krys/"
  },
  {
   "rank": 4,
   "holding": "Ligand Pharmaceuticals Inc",
   "ticker": "LGND",
   "weight_pct": 4.622,
   "page": "https://etfiq.com/holdings/lgnd/"
  },
  {
   "rank": 5,
   "holding": "Adaptive Biotechnologies Corp",
   "ticker": "ADPT",
   "weight_pct": 3.989,
   "page": "https://etfiq.com/holdings/adpt/"
  },
  {
   "rank": 6,
   "holding": "United Therapeutics Corp",
   "ticker": "UTHR",
   "weight_pct": 3.509,
   "page": "https://etfiq.com/holdings/uthr/"
  },
  {
   "rank": 7,
   "holding": "Bridgebio Pharma Inc",
   "ticker": "BBIO",
   "weight_pct": 3.5,
   "page": "https://etfiq.com/holdings/bbio/"
  },
  {
   "rank": 8,
   "holding": "Eli Lilly & Co",
   "ticker": "LLY",
   "weight_pct": 2.954,
   "page": "https://etfiq.com/holdings/lly/"
  },
  {
   "rank": 9,
   "holding": "Twist Bioscience Corp",
   "ticker": "TWST",
   "weight_pct": 2.849,
   "page": "https://etfiq.com/holdings/twst/"
  },
  {
   "rank": 10,
   "holding": "Vertex Pharmaceuticals Inc",
   "ticker": "VRTX",
   "weight_pct": 2.747,
   "page": "https://etfiq.com/holdings/vrtx/"
  },
  {
   "rank": 11,
   "holding": "Astrazeneca PLC",
   "ticker": "AZN",
   "weight_pct": 2.701,
   "page": "https://etfiq.com/holdings/azn/"
  },
  {
   "rank": 12,
   "holding": "Travere Therapeutics Inc",
   "ticker": "TVTX",
   "weight_pct": 2.593,
   "page": "https://etfiq.com/holdings/tvtx/"
  },
  {
   "rank": 13,
   "holding": "Insmed Inc",
   "ticker": "INSM",
   "weight_pct": 2.438,
   "page": "https://etfiq.com/holdings/insm/"
  },
  {
   "rank": 14,
   "holding": "Samsung Biologics Co Ltd",
   "ticker": "207940",
   "weight_pct": 2.256,
   "page": "https://etfiq.com/holdings/207940/"
  },
  {
   "rank": 15,
   "holding": "Corteva Inc",
   "ticker": "CTVA",
   "weight_pct": 2.254,
   "page": "https://etfiq.com/holdings/ctva/"
  },
  {
   "rank": 16,
   "holding": "Medpace Holdings Inc",
   "ticker": "MEDP",
   "weight_pct": 2.148,
   "page": "https://etfiq.com/holdings/medp/"
  },
  {
   "rank": 17,
   "holding": "Alnylam Pharmaceuticals Inc",
   "ticker": "ALNY",
   "weight_pct": 1.957,
   "page": "https://etfiq.com/holdings/alny/"
  },
  {
   "rank": 18,
   "holding": "Tempus AI Inc",
   "ticker": "TEM",
   "weight_pct": 1.949,
   "page": "https://etfiq.com/holdings/tem/"
  },
  {
   "rank": 19,
   "holding": "Ionis Pharmaceuticals Inc",
   "ticker": "IONS",
   "weight_pct": 1.913,
   "page": "https://etfiq.com/holdings/ions/"
  },
  {
   "rank": 20,
   "holding": "Neurocrine Biosciences Inc",
   "ticker": "NBIX",
   "weight_pct": 1.845,
   "page": "https://etfiq.com/holdings/nbix/"
  },
  {
   "rank": 21,
   "holding": "Regeneron Pharmaceuticals Inc",
   "ticker": "REGN",
   "weight_pct": 1.797,
   "page": "https://etfiq.com/holdings/regn/"
  },
  {
   "rank": 22,
   "holding": "Veracyte Inc",
   "ticker": "VCYT",
   "weight_pct": 1.644,
   "page": "https://etfiq.com/holdings/vcyt/"
  },
  {
   "rank": 23,
   "holding": "Argenx SE",
   "ticker": "ARGX",
   "weight_pct": 1.64,
   "page": "https://etfiq.com/holdings/argx/"
  },
  {
   "rank": 24,
   "holding": "PTC Therapeutics Inc",
   "ticker": "PTCT",
   "weight_pct": 1.463,
   "page": "https://etfiq.com/holdings/ptct/"
  },
  {
   "rank": 25,
   "holding": "BioNTech SE",
   "ticker": "BNTX",
   "weight_pct": 1.384,
   "page": null
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash and other net assets",
   "weight_pct": 1.269
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/helx/holdings/helx-holdings.csv",
 "json_book": "https://etfiq.com/data/books/helx.json",
 "markdown": "https://etfiq.com/funds/helx/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of HELX, data as of Jun 30, 2026. https://etfiq.com/funds/helx/holdings/"
}